Innate immunity drives xenobiotic-induced murine autoimmune cholangitis

Clinical and Experimental Immunology

Volumn 177, Issue 2, 2014, Pages 373-380

  Chang, C H ^a   Chen, Y C ^a   Yu, Y H ^a   Tao, M H ^b   Leung, P S C ^c   Ansari, A A ^d   Gershwin, M E ^c   Chuang, Y H ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 knock out mice; CD8 knock out mice; Primary biliary cirrhosis; Xenobiotics

Indexed keywords

2 OCTYNOIC ACID; ALPHA GALACTOSYLCERAMIDE; BOVINE SERUM ALBUMIN; CD4 ANTIGEN; CD8 ANTIGEN; MITOCHONDRION ANTIBODY; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE CHOLANGITIS; AUTOIMMUNE DISEASE; CHOLANGITIS; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; KNOCKOUT MOUSE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENT DISEASE;

CD4 KNOCK-OUT MICE; CD8 KNOCK-OUT MICE; PRIMARY BILIARY CIRRHOSIS; XENOBIOTICS;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHOLANGITIS; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; FATTY ACIDS, MONOUNSATURATED; FEMALE; GALACTOSYLCERAMIDES; IMMUNITY, INNATE; LIVER; LIVER CIRRHOSIS, BILIARY; MICE; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; SERUM ALBUMIN, BOVINE; XENOBIOTICS;

EID: 84903935519     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12298     Document Type: Article

References (48)

1. Silveira MG, Talwalkar JA, Lindor KD, Wiesner RH. Recurrent primary biliary cirrhosis after liver transplantation. Am J Transplant 2010; 10:720-726.
2. Manousou P, Arvaniti V, Tsochatzis E etal. Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity. Liver Transpl 2010; 16:64-73.
3. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138:3525-3531.
4. Silveira MG, Lindor KD. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. Clin Liver Dis 2008; 12:425-443; x-xi.
5. Shimoda S, Van de Water J, Ansari A etal. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998; 102:1831-1840.
6. Kita H, Lian ZX, Van de Water J etal. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 2002; 195:113-123.
7. Kita H, Matsumura S, He XS etal. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002; 109:1231-1240.
8. Yang GX, Lian ZX, Chuang YH etal. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 2008; 47:1974-1982.
9. Harada K, Van de Water J, Leung PS etal. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25:791-796.
10. Nagano T, Yamamoto K, Matsumoto S etal. Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 1999; 19:422-427.
11. Lan RY, Salunga TL, Tsuneyama K etal. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 2009; 32:43-51.
12. Rong G, Zhou Y, Xiong Y etal. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 2009; 156:217-225.
13. Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 2009; 157:261-270.
14. Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 1996; 80:311-320.
15. Kawata K, Yang GX, Ando Y etal. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 2013; 58:1094-1104.
16. Rong GH, Yang GX, Ando Y etal. Human intrahepatic biliary epithelial cells engulf blebs from their apoptotic peers. Clin Exp Immunol 2013; 172:95-103.
17. Selmi C, Leung PS, Sherr DH etal. Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 2012; 39:272-284.
18. Tanaka H, Yang GX, Iwakoshi N etal. Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 2013; 174:364-371.
19. Tian Z, Gershwin ME, Zhang C. Regulatory NK cells in autoimmune disease. J Autoimmun 2012; 39:206-215.
20. Kita H, Naidenko OV, Kronenberg M etal. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002; 123:1031-1043.
21. Tsuneyama K, Yasoshima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 1998; 28:620-623.
22. Hudspeth K, Pontarini E, Tentorio P etal. The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun 2013; 46:55-65.
23. Chuang YH, Lian ZX, Yang GX etal. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 2008; 47:571-580.
24. Wu SJ, Yang YH, Tsuneyama K etal. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 2011; 53:915-925.
25. Oertelt S, Lian ZX, Cheng CM etal. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006; 177:1655-1660.
26. Irie J, Wu Y, Wicker LS etal. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006; 203:1209-1219.
27. Wakabayashi K, Lian ZX, Moritoki Y etal. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 2006; 44:1240-1249.
28. Wakabayashi K, Lian ZX, Leung PS etal. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008; 48:531-540.
29. Ando Y, Yang GX, Kenny TP etal. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse. J Autoimmun 2013; 41:111-119.
30. Mayer CT, Tian L, Hesse C etal. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals. J Autoimmun 2014; epub.
31. Wang J, Yang GX, Zhang W etal. Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in NOD.B6 (Idd10/Idd18) mice. Clin Exp Immunol 2013; 175:192-201.
32. Yang CY, Ma X, Tsuneyama K etal. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 2014; epub.
33. Dhirapong A, Yang GX, Nadler S etal. Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology 2013; 57:708-715.
34. Tada Y, Ho A, Koh DR, Mak TW. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 1996; 156:4520-4526.
35. D'Acquisto F, Crompton T. CD3+CD4-CD8- (double negative) T cells: saviours or villains of the immune response? Biochem Pharmacol 2011; 82:333-340.
36. Blink SE, Miller SD. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Curr Mol Med 2009; 9:15-22.
37. Crispin JC, Oukka M, Bayliss G etal. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181:8761-8766.
38. Shimonkevitz R, Colburn C, Burnham JA, Murray RS, Kotzin BL. Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis. Proc Natl Acad Sci USA 1993; 90:923-927.
39. Masuda T, Ohteki T, Abo T etal. Expansion of the population of double negative CD4-8- T alpha beta-cells in the liver is a common feature of autoimmune mice. J Immunol 1991; 147:2907-2912.
40. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28:445-489.
41. Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008; 31:252-256.
42. Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmun Rev 2014; 13:441-444.
43. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993; 11:331-360.
44. Harris DP, Koch S, Mullen LM, Swain SL. B cell immunodeficiency fails to develop in CD4-deficient mice infected with BM5: murine AIDS as a multistep disease. J Immunol 2001; 166:6041-6049.
45. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008; 47:737-745.
46. He XS, Ansari AA, Ridgway WM, Coppel RL, Gershwin ME. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 2006; 239:1-13.
47. Chuang YH, Ridgway WM, Ueno Y, Gershwin ME. Animal models of primary biliary cirrhosis. Clin Liver Dis 2008; 12:333-347; ix.
48. Chen RC, Naiyanetr P, Shu SA etal. Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology 2013; 57:1498-1508.